C109H83Cl5N32O7S4 — CID 159894729
3-(benzylamino)-6-(4-chloro-1,3-benzothiazol-6-yl)-5-(3-methylpyrazol-1-yl)pyrazine-2-carbonitrile;3-(benzylamino)-6-(7-chloro-1H-indazol-5-yl)-5-(3-methylpyrazol-1-yl)pyrazine-2-carboxamide;3-(benzylamino)-6-(4-chloronaphthalen-2-yl)-5-phenylpyrazine-2-carboxamide;N-[5-(4-chloro-1,3-benzothiazol-6-yl)-3-cyano-6-(3-methylpyrazol-1-yl)pyrazin-2-yl]methanesulfonamide;N-[6-(8-chloroquinolin-6-yl)-5-(3-methylpyrazol-1-yl)-2-oxo-1H-pyrazin-3-yl]methanesulfonamide (PubChem CID 159894729) has the molecular formula C109H83Cl5N32O7S4 and a molecular weight of 2258.61 g/mol. Its IUPAC name is 3-(benzylamino)-6-(4-chloro-1,3-benzothiazol-6-yl)-5-(3-methylpyrazol-1-yl)pyrazine-2-carbonitrile;3-(benzylamino)-6-(7-chloro-1H-indazol-5-yl)-5-(3-methylpyrazol-1-yl)pyrazine-2-carboxamide;3-(benzylamino)-6-(4-chloronaphthalen-2-yl)-5-phenylpyrazine-2-carboxamide;N-[5-(4-chloro-1,3-benzothiazol-6-yl)-3-cyano-6-(3-methylpyrazol-1-yl)pyrazin-2-yl]methanesulfonamide;N-[6-(8-chloroquinolin-6-yl)-5-(3-methylpyrazol-1-yl)-2-oxo-1H-pyrazin-3-yl]methanesulfonamide.
| Compound Name | 3-(benzylamino)-6-(4-chloro-1,3-benzothiazol-6-yl)-5-(3-methylpyrazol-1-yl)pyrazine-2-carbonitrile;3-(benzylamino)-6-(7-chloro-1H-indazol-5-yl)-5-(3-methylpyrazol-1-yl)pyrazine-2-carboxamide;3-(benzylamino)-6-(4-chloronaphthalen-2-yl)-5-phenylpyrazine-2-carboxamide;N-[5-(4-chloro-1,3-benzothiazol-6-yl)-3-cyano-6-(3-methylpyrazol-1-yl)pyrazin-2-yl]methanesulfonamide;N-[6-(8-chloroquinolin-6-yl)-5-(3-methylpyrazol-1-yl)-2-oxo-1H-pyrazin-3-yl]methanesulfonamide |
|---|---|
| PubChem CID | 159894729 |
| Molecular Formula | C109H83Cl5N32O7S4 |
| Molecular Weight | 2258.61 g/mol |
| Exact Mass | 2254.44 |
| IUPAC Name | 3-(benzylamino)-6-(4-chloro-1,3-benzothiazol-6-yl)-5-(3-methylpyrazol-1-yl)pyrazine-2-carbonitrile;3-(benzylamino)-6-(7-chloro-1H-indazol-5-yl)-5-(3-methylpyrazol-1-yl)pyrazine-2-carboxamide;3-(benzylamino)-6-(4-chloronaphthalen-2-yl)-5-phenylpyrazine-2-carboxamide;N-[5-(4-chloro-1,3-benzothiazol-6-yl)-3-cyano-6-(3-methylpyrazol-1-yl)pyrazin-2-yl]methanesulfonamide;N-[6-(8-chloroquinolin-6-yl)-5-(3-methylpyrazol-1-yl)-2-oxo-1H-pyrazin-3-yl]methanesulfonamide |
| SMILES | Cc1ccn(-c2nc(NCc3ccccc3)c(C#N)nc2-c2cc(Cl)c3ncsc3c2)n1.Cc1ccn(-c2nc(NCc3ccccc3)c(C(N)=O)nc2-c2cc(Cl)c3[nH]ncc3c2)n1.Cc1ccn(-c2nc(NS(C)(=O)=O)c(=O)[nH]c2-c2cc(Cl)c3ncccc3c2)n1.Cc1ccn(-c2nc(NS(C)(=O)=O)c(C#N)nc2-c2cc(Cl)c3ncsc3c2)n1.NC(=O)c1nc(-c2cc(Cl)c3ccccc3c2)c(-c2ccccc2)nc1NCc1ccccc1 |
| InChI | InChI=1S/C28H21ClN4O.C23H19ClN8O.C23H16ClN7S.C18H15ClN6O3S.C17H12ClN7O2S2/c29-23-16-21(15-20-13-7-8-14-22(20)23)25-24(19-11-5-2-6-12-19)33-28(26(32-25)27(30)34)31-17-18-9-3-1-4-10-18;1-13-7-8-32(31-13)23-19(15-9-16-12-27-30-18(16)17(24)10-15)28-20(21(25)33)22(29-23)26-11-14-5-3-2-4-6-14;1-14-7-8-31(30-14)23-20(16-9-17(24)21-19(10-16)32-13-27-21)28-18(11-25)22(29-23)26-12-15-5-3-2-4-6-15;1-10-5-7-25(23-10)17-15(21-18(26)16(22-17)24-29(2,27)28)12-8-11-4-3-6-20-14(11)13(19)9-12;1-9-3-4-25(23-9)17-14(10-5-11(18)15-13(6-10)28-8-20-15)21-12(7-19)16(22-17)24-29(2,26)27/h1-16H,17H2,(H2,30,34)(H,31,33);2-10,12H,11H2,1H3,(H2,25,33)(H,26,29)(H,27,30);2-10,13H,12H2,1H3,(H,26,29);3-9H,1-2H3,(H,21,26)(H,22,24);3-6,8H,1-2H3,(H,22,24) |
| InChIKey | NVEUIHWOTVQMNP-UHFFFAOYSA-N |
| XLogP | 21.24 |
| TPSA | 549.69 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 25 |
| Heavy Atoms | 157 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2258.61 |
| LogP ≤ 5 | 21.24 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 35 |